India: Varenacline Patent revoked

Varenaciline is marketed by Pfizer world wide as Chandix or Champix. Varenaciline is marketed as tartarate salt form, this salt form is protected by US patent 6890927 and its indian equivalent is 204091 (863/MUMNP/2003).

This ‘091 patent is opposed by Dr Reddy’s under section 25(2). Patent is revoked on lack novelty under 25(2)(b) and not an invention under 3(d). Interestingly granted claim 1 of ‘091 patent seems to be product claim of varenacline not as tartarate salt.


Decision date is May 23, 2011.

About Guna

Interested to learn things around me
This entry was posted in Patent case and tagged , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s